We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$67.3B
AUM Growth
+$5.8B
Cap. Flow
+$761M
Cap. Flow %
1.13%
Top 10 Hldgs %
16.93%
Holding
3,547
New
263
Increased
1,557
Reduced
1,465
Closed
162
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBI icon
3251
Pitney Bowes
PBI
$2.28B
$73.2K ﹤0.01%
+16,907
New +$69.7K
CDTX
3252
DELISTED
Cidara Therapeutics
CDTX
$71.3K ﹤0.01%
3,878
-65
-2% -$933
AQST icon
3253
Aquestive Therapeutics
AQST
$531M
$70.3K ﹤0.01%
+16,500
New +$54.9K
ERIC icon
3254
Ericsson
ERIC
$33.4B
$70K ﹤0.01%
12,704
-74,898
-85% -$422K
EVLV icon
3255
Evolv Technologies
EVLV
$1.03B
$69.8K ﹤0.01%
15,685
+1,925
+14% +$8.32K
CYH icon
3256
Community Health Systems
CYH
$410M
$68.7K ﹤0.01%
19,635
GRFS
3257
Grifois
GRFS
$5.4B
$68.3K ﹤0.01%
10,220
OABI icon
3258
OmniAb
OABI
$497M
$67.4K ﹤0.01%
+12,431
New +$71.6K
AMC icon
3259
AMC Entertainment Holdings
AMC
$2.26B
$67.1K ﹤0.01%
+18,035
New +$80.3K
ORIO
3260
Orion Digital Corp
ORIO
$19.8M
$66.5K ﹤0.01%
+33,265
New +$60K
MU icon
3261
PUT
Micron Technology
MU
$1.03T
$66.5K ﹤0.01%
+700
New +$63.4K
OPK icon
3262
Opko Health
OPK
$1.04B
$66.3K ﹤0.01%
55,234
+3,380
+7% +$3.38K
ME
3263
DELISTED
23andMe Holding Co
ME
$65.7K ﹤0.01%
6,176
+4,744
+331% +$61K
GCV
3264
Gabelli Convertible and Income Securities Fund
GCV
$95.3M
$65.3K ﹤0.01%
17,607
+999
+6% +$3.64K
AKTS
3265
DELISTED
Akoustis Technologies Inc
AKTS
$62.6K ﹤0.01%
105,908
+5,125
+5% +$3.31K
QSI icon
3266
Quantum-Si Incorporated
QSI
$182M
$60.1K ﹤0.01%
30,500
SBSW icon
3267
Sibanye-Stillwater
SBSW
$7.58B
$59.8K ﹤0.01%
12,698
+24
+0.2% +$110
SACH
3268
Sachem Capital Corp
SACH
$38.4M
$59.8K ﹤0.01%
13,400
-730
-5% -$2.81K
TELL
3269
DELISTED
Tellurian Inc.
TELL
$58.9K ﹤0.01%
89,105
+1,126
+1% +$764
QURE icon
3270
uniQure
QURE
$3.13B
$58.9K ﹤0.01%
+11,321
New +$65K
FSP
3271
Franklin Street Properties
FSP
$46.3M
$58.5K ﹤0.01%
25,760
CTSO icon
3272
Cytosorbents Corp
CTSO
$23.3M
$57.6K ﹤0.01%
60,591
GRTS
3273
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$56.7K ﹤0.01%
22,073
SMR icon
3274
NuScale Power
SMR
$3.94B
$56.4K ﹤0.01%
10,616
-200
-2% -$718
GNSS icon
3275
Genasys
GNSS
$77.4M
$55.8K ﹤0.01%
23,560
+1,000
+4% +$1.84K

Similar funds

Raymond James Financial Services Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James Financial Services Advisors held 3,547 positions worth $67.3B, up 9.4% from $61.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James Financial Services Advisors's Q1 2024 filing shows 263 new, 1,557 increased, 1,465 reduced and 162 closed positions. Its largest new stake was JPMorgan Equity Focus ETF: 475,290 shares worth $28.4M. The largest sale was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund, an estimated $73M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q1 2024 buy was JPMorgan Equity Focus ETF: 475,290 shares worth $28.4M.
  • Raymond James Financial Services Advisors added most to DexCom in Q1 2024, an estimated $53.5M increase.
  • Raymond James Financial Services Advisors's biggest Q1 2024 reduction was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund, cutting an estimated $73M.
  • Raymond James Financial Services Advisors fully exited Invesco Equal Weight 0-30 Year Treasury ETF in Q1 2024, selling an estimated $16.8M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 17% of its $67.3B portfolio in Q1 2024.
  • Raymond James Financial Services Advisors opened 263 new positions and closed 162 in Q1 2024.
  • Raymond James Financial Services Advisors's portfolio value rose 9.4% quarter-over-quarter to $67.3B.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.